22UA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioNTech SE

Watchlist Manager

Watchlist

Price: 82 EUR -1.74% Market Closed

Market Cap: €19.8B

B	BioNTech SE F:22UA	DE
A	Agnico Eagle Mines Ltd DUS:AE9	CA
	Shinkin Central Bank TSE:8421	JP
P	PharmaSGP Holding SE DUS:PSG	DE

Profitability Summary

BioNTech SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

85%

Declining Gross Margin

87% > 82%

Negative Operating Margin

-22%

Negative 3Y Average Operating Margin

-4%

Declining Operating Margin

64% > -22%

Negative Net Margin

-45%

Negative 3Y Average Net Margin

-7%

Declining Net Margin

48% > -45%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

35%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.